Abrilumab
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Abrilumab (INN; development code AMG 181) is a monoclonal antibody designed for the treatment of inflammatory bowel disease, ulcerative colitis, and Crohn's disease. This drug was developed by MedImmune.
Abrilumab (INN; development code AMG 181) is a monoclonal antibody designed for the treatment of inflammatory bowel disease, ulcerative colitis, and Crohn's disease. This drug was developed by MedImmune.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1190942300 under CC BY-SA 4.0; modifications have been made.